Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
1.
Respir Res ; 23(1): 165, 2022 Jun 22.
Artigo em Inglês | MEDLINE | ID: mdl-35733161

RESUMO

BACKGROUND: Asthma is a major cause of morbidity and mortality in humans. The mechanisms of asthma are still not fully understood. Leukocyte-specific protein-1 (LSP-1) regulates neutrophil migration during acute lung inflammation. However, its role in asthma remains unknown. METHODS: An OVA-induced mouse asthma model in LSP1-deficient (Lsp1-/-) and wild-type (WT) 129/SvJ mice were used to test the hypothesis that the absence of LSP1 would inhibit airway hyperresponsiveness and lung inflammation. RESULTS: Light and electron microscopic immunocytochemistry and Western blotting showed that, compared with normal healthy lungs, the levels of LSP1 were increased in lungs of OVA-asthmatic mice. Compared to Lsp1-/- OVA mice, WT OVA mice had higher levels of leukocytes in broncho-alveolar lavage fluid and in the lung tissues (P < 0.05). The levels of OVA-specific IgE but not IgA and IgG1 in the serum of WT OVA mice was higher than that of Lsp1-/- OVA mice (P < 0.05). Deficiency of LSP1 significantly reduced the levels of IL-4, IL-5, IL-6, IL-13, and CXCL1 (P < 0.05) but not total proteins in broncho-alveolar lavage fluid in asthmatic mice. The airway hyper-responsiveness to methacholine in Lsp1-/- OVA mice was improved compared to WT OVA mice (P < 0.05). Histology revealed more inflammation (inflammatory cells, and airway and blood vessel wall thickening) in the lungs of WT OVA mice than in those of Lsp1-/- OVA mice. Finally, immunohistology showed localization of LSP1 protein in normal and asthmatic human lungs especially associated with the vascular endothelium and neutrophils. CONCLUSION: These data show that LSP1 deficiency reduces airway hyper-responsiveness and lung inflammation, including leukocyte recruitment and cytokine expression, in a mouse model of asthma.


Assuntos
Asma , Hipersensibilidade Respiratória , Animais , Asma/metabolismo , Líquido da Lavagem Broncoalveolar , Modelos Animais de Doenças , Inflamação/metabolismo , Pulmão/metabolismo , Camundongos , Camundongos Endogâmicos BALB C , Neutrófilos/metabolismo , Ovalbumina/toxicidade , Hipersensibilidade Respiratória/metabolismo
2.
Respir Res ; 22(1): 69, 2021 Feb 25.
Artigo em Inglês | MEDLINE | ID: mdl-33632209

RESUMO

BACKGROUND: CD34, a pan-selectin binding protein when glycosylated, has been shown to be involved in leukocyte migration to the site of inflammation. However, only one report is available on the expression and role of CD34 in neutrophil recruitment during acute lung inflammation. METHODS: We proceeded to study the role of CD34 in lung neutrophil migration using mouse model of endotoxin induced acute lung inflammation and studied over multiple time points, in generic CD34 knock-out (KO) strain. RESULTS: While there was no difference in BAL total or differential leukocyte counts, lung MPO content was lower in LPS exposed KO compared to WT group at 3 h time-point (p = 0.0308). The MPO levels in CD34 KO mice begin to rise at 9 h (p = 0.0021), as opposed to an early 3 h rise in WT mice (p = 0.0001), indicating that KO mice display delays in lung neutrophil recruitment kinetics. KO mice do not loose endotoxin induced lung vascular barrier properties as suggested by lower BAL total protein at 3 h (p = 0.0452) and 24 h (p = 0.0113) time-points. Several pro-inflammatory cytokines and chemokines (TNF-α, IL-1ß, KC, MIP-1α, IL-6, IL-10 and IL-12 p70 sub-unit; p < 0.05) had higher levels in WT compared to KO group, at 3 h. Lung immunofluorescence in healthy WT mice reveals CD34 expression in the bronchiolar epithelium, in addition to alveolar septa. CONCLUSION: Thus, given CD34's pan-selectin affinity, and expression in the bronchiolar epithelium as well as alveolar septa, our study points towards a role of CD34 in lung neutrophil recruitment but not alveolar migration, cytokine expression and lung inflammation.


Assuntos
Antígenos CD34/metabolismo , Mediadores da Inflamação/metabolismo , Lipopolissacarídeos/toxicidade , Pneumonia/induzido quimicamente , Pneumonia/metabolismo , Animais , Antígenos CD34/genética , Endotoxinas/toxicidade , Feminino , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Infiltração de Neutrófilos/efeitos dos fármacos , Infiltração de Neutrófilos/fisiologia , Pneumonia/genética
3.
Am J Physiol Lung Cell Mol Physiol ; 306(1): L58-68, 2014 Jan 01.
Artigo em Inglês | MEDLINE | ID: mdl-24213918

RESUMO

Acute lung injury is marked by profound influx of activated neutrophils, which have delayed apoptosis, along with fluid accumulation that impairs lung function and causes high mortality. Inflammatory and antimicrobial molecules, such as reactive oxygen species from activated neutrophils with prolonged lifespan, cause tissue damage and contribute to lung dysfunction. Angiostatin, an endogenous antiangiogenic molecule, is expressed in the lavage fluid of patients with acute respiratory distress syndrome and modifies neutrophil infiltration in a mouse model of peritonitis. Our aim was to investigate the therapeutic role of angiostatin in acute lung injury. We analyzed bronchoalveolar lavage and lung tissues from C57BL/6 mouse model of Escherichia coli LPS-induced acute lung injury to assess the effects of angiostatin treatment. Subcutaneous angiostatin administered at 5 h after LPS treatment reduces histological signs of inflammation, protein accumulation, lung Gr1+ neutrophils, myeloperoxidase activity, and expression of phosphorylated p38 MAPK in lung tissues and peripheral blood neutrophils, while increasing the number of apoptotic cells in the lungs without affecting the levels of macrophage inflammatory protein-1 α, IL-1ß, keratinocyte chemoattractant, and monocyte chemoattractant protein-1 in lavage and lung homogenates at 9 and 24 h after LPS treatment. In contrast, angiostatin administered intravenously 5 h after LPS treatment did not reduce histological sign of inflammation, BAL cell recruitment, and protein concentration at 9 h of LPS treatment. We conclude that angiostatin administered subcutaneously after LPS challenge inhibits acute lung inflammation up to 24 h after LPS treatment.


Assuntos
Lesão Pulmonar Aguda/imunologia , Angiostatinas/administração & dosagem , Anti-Inflamatórios/administração & dosagem , Lesão Pulmonar Aguda/tratamento farmacológico , Lesão Pulmonar Aguda/metabolismo , Angiostatinas/farmacologia , Animais , Anti-Inflamatórios/farmacologia , Apoptose , Líquido da Lavagem Broncoalveolar , Modelos Animais de Doenças , Injeções Subcutâneas , Lipopolissacarídeos/farmacologia , Pulmão/imunologia , Pulmão/metabolismo , Pulmão/patologia , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Infiltração de Neutrófilos/efeitos dos fármacos , Neutrófilos/efeitos dos fármacos , Neutrófilos/enzimologia , Neutrófilos/imunologia , Peroxidase/metabolismo , Proteínas Quinases p38 Ativadas por Mitógeno/metabolismo
4.
Cell Tissue Res ; 355(2): 375-96, 2014 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-24297047

RESUMO

There is a critical need to identify molecules that modulate the biology of neutrophils because activated neutrophils, though necessary for host defense, cause exuberant tissue damage through production of reactive oxygen species and increased lifespan. Angiostatin, an endogenous anti-angiogenic cleavage product of plasminogen, binds to integrin αvß3, ATP synthase and angiomotin and its expression is increased in inflammatory conditions. We test the hypothesis that angiostatin inhibits neutrophil activation, induces apoptosis and blocks recruitment in vivo and in vitro. The data show immuno-reactivity for plasminogen/angiostatin in resting neutrophils. Angiostatin conjugated to FITC revealed that angiostatin was endocytozed by activated mouse and human neutrophils in a lipid raft-dependent fashion. Co-immunoprecipitation of human neutrophil lysates, confocal microscopy of isolated mouse and human neutrophils and functional blocking experiments showed that angiostatin complexes with flotillin-1 along with integrin αvß3 and ATP synthase. Angiostatin inhibited fMLP-induced neutrophil polarization, as well as caused inhibition of hsp-27 phosphorylation and stabilization of microtubules. Angiostatin treatment, before or after LPS-induced neutrophil activation, inhibited phosphorylation of p38 and p44/42 MAPKs, abolished reactive oxygen species production and released the neutrophils from suppressed apoptosis, as indicated by expression of activated caspase-3 and morphological evidence of apoptosis. Finally, intravital microscopy and myeloperoxidase assay showed inhibition of neutrophil recruitment in post-capillary venules of TNFα-treated cremaster muscle in mouse. These in vitro and in vivo data demonstrate angiostatin as a broad deactivator and silencer of neutrophils and an inhibitor of their migration. These data potentially open new avenues for the development of anti-inflammatory drugs.


Assuntos
Angiostatinas/farmacologia , Movimento Celular/efeitos dos fármacos , Ativação de Neutrófilo/efeitos dos fármacos , Neutrófilos/citologia , Animais , Apoptose/efeitos dos fármacos , Antígenos CD18/metabolismo , Polaridade Celular/efeitos dos fármacos , Endocitose/efeitos dos fármacos , Humanos , Inflamação/patologia , Lipopolissacarídeos/farmacologia , Sistema de Sinalização das MAP Quinases/efeitos dos fármacos , Microdomínios da Membrana/efeitos dos fármacos , Microdomínios da Membrana/metabolismo , Proteínas de Membrana/metabolismo , Camundongos , Microtúbulos/efeitos dos fármacos , Microtúbulos/metabolismo , Mitocôndrias/metabolismo , Músculos/efeitos dos fármacos , Músculos/metabolismo , Músculos/patologia , N-Formilmetionina Leucil-Fenilalanina/farmacologia , Infiltração de Neutrófilos/efeitos dos fármacos , Neutrófilos/efeitos dos fármacos , Neutrófilos/enzimologia , Oxirredução/efeitos dos fármacos , Subunidades Proteicas/metabolismo , ATPases Translocadoras de Prótons/metabolismo , Espécies Reativas de Oxigênio/metabolismo , Fator de Necrose Tumoral alfa/farmacologia
5.
Can J Vet Res ; 87(1): 9-16, 2023 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-36606044

RESUMO

Endotoxin-induced diseases cause significant mortality and morbidity in the horse, leading to enormous economic damage to the equine industry. Neutrophils play a critical role in initiating the immune response in the lung. Pattern recognition receptors (PRRs) are programmed to recognize microbial structures unique to pathogens and mount an immune response. Pentraxin 3 (PTX3) is a PRR that is produced at sites of inflammation by many cell types upon stimulation by pro-inflammatory cytokines and agonists, such as endotoxins [also known as lipopolysaccharides (LPS)]. Pentraxin 3 recognizes and binds to many pathogens, activates the complement cascade, and has a role in the clearance of apoptotic and necrotic cells. Recently, PTX3 has been reported to be localized in the specific granules in human and mouse neutrophils, but no reports exist on the in-situ localization of PTX3 in neutrophils and the lungs of horses. Therefore, the objective of this study was to localize the PTX3 protein in normal and LPS-exposed neutrophils and in normal equine lungs. Immunohistochemical data showed PTX3 staining in the bronchial epithelial cells and the vascular endothelium of normal lungs. Immunogold electron microscopy localized PTX3 in the nuclei, cytoplasm, and vesicular organelles of alveolar macrophages, endothelial cells, and pulmonary intravascular macrophages. Immunohistochemical staining for PTX3 in isolated horse neutrophils showed an altered staining pattern in neutrophils stimulated with LPS. These data suggest that neutrophils may be a mobile form of PTX3 that is readily shuttled to the site of inflammation, where it can be released to fine tune a host defense response.


Les maladies induites par les endotoxines provoquent une mortalité et une morbidité importantes chez le cheval, entraînant d'énormes dommages économiques pour l'industrie équine. Les neutrophiles jouent un rôle essentiel dans le déclenchement de la réponse immunitaire dans les poumons. Les récepteurs de reconnaissance de formes (PRR) sont programmés pour reconnaître les structures microbiennes propres aux agents pathogènes et déclencher une réponse immunitaire. La pentraxine 3 (PTX3) est un PRR qui est produit sur les sites d'inflammation par de nombreux types de cellules lors de la stimulation par des cytokines pro-inflammatoires et des agonistes, tels que les endotoxines [également appelées lipopolysaccharides (LPS)]. La pentraxine 3 reconnaît et se lie à de nombreux agents pathogènes, active la cascade du complément et joue un rôle dans la clairance des cellules apoptotiques et nécrotiques. Récemment, il a été rapporté que PTX3 était localisé dans les granules spécifiques des neutrophiles humains et de souris, mais aucun rapport n'existe sur la localisation in situ de PTX3 dans les neutrophiles et les poumons des chevaux. Par conséquent, l'objectif de cette étude était de localiser la protéine PTX3 dans les neutrophiles normaux et exposés au LPS et dans les poumons équins normaux. Les données immunohistochimiques ont montré une coloration PTX3 dans les cellules épithéliales bronchiques et l'endothélium vasculaire des poumons normaux. La microscopie électronique d'immunomarquage à l'or colloïdal a localisé PTX3 dans les noyaux, le cytoplasme et les organites vésiculaires des macrophages alvéolaires, des cellules endothéliales et des macrophages intravasculaires pulmonaires. La coloration immunohistochimique de PTX3 dans des neutrophiles de cheval isolés a montré un schéma de coloration altéré dans les neutrophiles stimulés avec du LPS. Ces données suggèrent que les neutrophiles peuvent être une forme mobile de PTX3 qui est facilement acheminée vers le site de l'inflammation, où elle peut être libérée pour affiner une réponse de défense de l'hôte.(Traduit par Docteur Serge Messier).


Assuntos
Proteína C-Reativa , Doenças dos Cavalos , Componente Amiloide P Sérico , Animais , Proteína C-Reativa/metabolismo , Células Cultivadas , Células Endoteliais/metabolismo , Cavalos , Inflamação/metabolismo , Inflamação/veterinária , Lipopolissacarídeos/farmacologia , Pulmão/metabolismo , Neutrófilos , Componente Amiloide P Sérico/metabolismo
6.
Cell Tissue Res ; 348(1): 177-87, 2012 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-22350844

RESUMO

Streptococcus pneumoniae is one of the most common causes of bacterial pneumonias in humans. Neutrophil migration into lungs infected with S. pneumoniae is central to the host defense but the mechanisms of neutrophil recruitment, as mediated by S. pneumoniae, into lungs are incompletely understood. Therefore, we have assessed the role of integrin αvß3 by evaluating its subunit ß3 in a mouse model of lung inflammation induced by S. pneumonia. Integrin subunit ß3 knockout (ß3(-/-)) and wild-type (WT) mice were intratracheally instilled with either S. pneumoniae or saline. Other groups of WT mice were treated intraperitoneally with 25 µg or 50 µg of antibody against integrin ß3 or with isotype-matched antibody at 1 h before instillation of S. pneumoniae. Mice were killed 24 h after infection. Flow cytometry confirmed the absence or presence of integrin subunit ß3 on peripheral blood neutrophils in ß3(-/-) or WT mice, respectively. Neutrophil numbers in bronchoalveolar lavage (BAL) from infected ß3(-/-) and WT mice showed no differences. Neutrophil numbers in BAL of infected WT mice treated with ß3 antibody were lower compared with those without antibody but similar to those of mice administered isotype-matched antibody. Many neutrophils were present in the perivascular spaces of the lungs in ß3(-/-) mice. Lungs from infected ß3(-/-) mice had negligible mitogen-activated protein kinase expression compared with those of infected WT mice. Thus, integrin ß3 or its heterodimer αvß3 is not critical for neutrophil migration into lungs infected with S. pneumoniae.


Assuntos
Integrina beta3/metabolismo , Infiltração de Neutrófilos/imunologia , Pneumonia Pneumocócica/imunologia , Pneumonia Pneumocócica/microbiologia , Animais , Modelos Animais de Doenças , Citometria de Fluxo , Imuno-Histoquímica , Contagem de Leucócitos , Pulmão/enzimologia , Pulmão/microbiologia , Pulmão/patologia , Camundongos , Neutrófilos/metabolismo , Fosforilação , Pneumonia/sangue , Pneumonia/complicações , Pneumonia/microbiologia , Pneumonia/patologia , Pneumonia Pneumocócica/complicações , Pneumonia Pneumocócica/patologia , Subunidades Proteicas/metabolismo , Proteínas Quinases p38 Ativadas por Mitógeno/metabolismo
7.
Ann Anat ; 239: 151774, 2022 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-34082080

RESUMO

Nucleobindin2 (NUCB2)/nesfatin-1 expression in human plasma positively correlates with the expression of pro-inflammatory cytokines in patients with chronic obstructive pulmonary disease (COPD), implicating its potential role in neutrophilic lung inflammation. There are no data on the localization of nucleobindin2 (NUCB2)/nesfatin-1 in human lungs and inflammatory cells. We examined the localization of NUCB2/nesfatin-1-immunoreactivity in normal and inflamed human lungs obtained from COPD patients and neutrophils with light and immunoelectron microscopy. Immunohistology showed localization of NUCB2/nesfatin-1-like immunoreactivity in the bronchiolar epithelium, alveolar septa, vascular endothelium and various immune cells of normal and inflamed lungs. Further, NUCB2/nesfatin-1-like immunoreactivity accumulated within 0.5 µm of the plasma membrane in human neutrophils following 90 min of 1 ng/mL LPS stimulation. NUCB2/nesfatin-1-like immunoreactivity was also found to localize in euchromatic portions of neutrophilic nuclei at five times the mean concentration compared to heterochromatin. Finally, our results indicate that NUCB2/nesfatin-1-like immunoreactivity is predominantly cytoplasmic including that in the Golgi complex and vesicles as it localizes at two times the concentration in neutrophilic cytoplasm compared to nucleus. Our study is the first to detail the localization of NUCB2/nesfatin-1-like immunoreactivity in lungs and neutrophils, and nuclear localization of NUCB2/nesfatin-1 also implicates its potential role in transcriptional regulation.


Assuntos
Neutrófilos , Nucleobindinas/genética , Humanos , Pulmão/imunologia , Neutrófilos/imunologia , Doença Pulmonar Obstrutiva Crônica/imunologia
8.
Can J Vet Res ; 85(3): 161-169, 2021 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-34248259

RESUMO

The cell surface protein CD34 is expressed in various human tissues and cells, including hematopoietic stem cells, vascular endothelial cells, mucosal dendritic cells, mast cells, eosinophils, microglia, fibrocytes, muscle satellite cells, and platelets. There is a lack of data on the expression of CD34 in canine and porcine tissues. Therefore, we designed a series of immunoblotting, immunohistochemistry, and immunofluorescence experiments to observe CD34 expression in murine, canine, and porcine lungs. We used a rabbit antibody (clone EP373Y) to target the conserved human CD34 C-terminal region and validated its immunoreactivity against mouse lung homogenates. The data showed diffuse bronchiolar and alveolar epithelial localization of CD34 protein in normal murine, canine, and porcine lungs. At 9 or 24 h after bacterial endotoxin exposure, murine CD34 protein shifted to specific bronchoalveolar cells with a punctate pattern, as quantified by CD34 fluorescence. Specific porcine bronchoalveolar cells and leukocytes had significant CD34-positive immunostaining after H3N1 influenza infection. Thus, our study provides fundamental data on the expression of CD34 in lungs and validates an antibody for use in further experiments in these animal species.


La protéine de surface cellulaire CD34 est exprimée dans divers tissus et cellules humains, y compris les cellules souches hématopoïétiques, les cellules endothéliales vasculaires, les cellules dendritiques des muqueuses, les mastocytes, les éosinophiles, la microglie, les fibrocytes, les cellules satellites musculaires et les plaquettes. Il existe un manque de données sur l'expression de CD34 dans les tissus canins et porcins. Par conséquent, nous avons conçu une série d'expériences d'immunobuvardage, d'immunohistochimie et d'immunofluorescence pour observer l'expression de CD34 dans les poumons murins, canins et porcins. Nous avons utilisé un anticorps de lapin (clone EP373Y) pour cibler la région C-terminale conservée du CD34 humain et validé son immunoréactivité contre des homogénats pulmonaires de souris. Les données ont montré une localisation épithéliale bronchiolaire et alvéolaire diffuse de la protéine CD34 dans les poumons normaux murins, canins et porcins. À 9 ou 24 h après l'exposition à l'endotoxine bactérienne, la protéine CD34 murine s'est déplacée vers des cellules bronchoalvéolaires spécifiques avec un motif ponctué, tel que quantifié par la fluorescence envers CD34. Des cellules bronchoalvéolaires et des leucocytes porcins spécifiques présentaient une immunocoloration significativement positive pour CD34 après une infection par le virus de l'influenza H3N1. Ainsi, notre étude fournit des données fondamentales sur l'expression de CD34 dans les poumons et valide un anticorps à utiliser dans d'autres expériences chez ces espèces animales.(Traduit par Docteur Serge Messier).


Assuntos
Antígenos CD34/metabolismo , Cães/metabolismo , Pulmão/metabolismo , Camundongos/metabolismo , Suínos/metabolismo , Animais , Antígenos CD34/genética , Células Epiteliais/metabolismo , Células Epiteliais/virologia , Vírus da Influenza A , Mucosa Respiratória/citologia , Especificidade da Espécie
9.
J Vis Exp ; (169)2021 03 21.
Artigo em Inglês | MEDLINE | ID: mdl-33818567

RESUMO

Lungs are continually faced with direct and indirect insults in the form of sterile (particles or reactive toxins) and infectious (bacterial, viral or fungal) inflammatory conditions. An overwhelming host response may result in compromised respiration and acute lung injury, which is characterized by lung neutrophil recruitment as a result of the patho-logical host immune, coagulative and tissue remodeling response. Sensitive microscopic methods to visualize and quantify murine lung cellular adaptations, in response to low-dose (0.05 ppm) ozone, a potent environmental pollutant in combination with bacterial lipopolysaccharide, a TLR4 agonist, are crucial in order to understand the host inflammatory and repair mechanisms. We describe a comprehensive fluorescent microscopic analysis of various lung and systemic body compartments, namely the broncho-alveolar lavage fluid, lung vascular perfusate, left lung cryosections, and sternal bone marrow perfusate. We show damage of alveolar macrophages, neutrophils, lung parenchymal tissue, as well as bone marrow cells in correlation with a delayed (up to 36-72 h) immune response that is marked by discrete chemokine gradients in the analyzed compartments. In addition, we present lung extracellular matrix and cellular cytoskeletal interactions (actin, tubulin), mitochondrial and reactive oxygen species, anti-coagulative plasminogen, its anti-angiogenic peptide fragment angiostatin, the mitochondrial ATP synthase complex V subunits, α and ß. These surrogate markers, when supplemented with adequate in vitro cell-based assays and in vivo animal imaging techniques such as intravital microscopy, can provide vital information towards understanding the lung response to novel immunomodulatory agents.


Assuntos
Lesão Pulmonar Aguda/diagnóstico por imagem , Lesão Pulmonar Aguda/imunologia , Lipopolissacarídeos/metabolismo , Infiltração de Neutrófilos/imunologia , Ozônio/imunologia , Animais , Modelos Animais de Doenças , Camundongos
10.
J Leukoc Biol ; 104(1): 147-158, 2018 07.
Artigo em Inglês | MEDLINE | ID: mdl-29633338

RESUMO

Leukocyte recruitment plays a critical role during both normal inflammation and chronic inflammatory diseases, and ongoing studies endeavor to better understand the complexities of this process. Focal adhesion kinase (FAK) is well known for its role in cancer, yet it also has been shown to regulate aspects of neutrophil and B16 melanoma cell recruitment by rapidly influencing endothelial cell focal adhesion dynamics and junctional opening. Recently, we found that FAK related non-kinase (FRNK), a protein that is often used as a FAK dominant negative, blocked eosinophil transmigration by preventing the transcription of vascular cell adhesion molecule-1 (VCAM-1) and eotaxin-3 (CCL26). Surprisingly, the blocking occurred even in the absence of endogenous FAK. To better understand the role of FAK in leukocyte recruitment, we used a FAK-specific inhibitor (PF-573228) and determined the effect on IL-4 induced eosinophil recruitment in vitro and in vivo. PF-573228 prevented the expression of VCAM-1 and CCL26 expression in IL-4-stimulated human endothelial cells in vitro. As a result, eosinophil adhesion and transmigration were blocked. PF-572338 also prevented IL-4-induced VCAM-1 expression in vivo. Using brightfield intravital microscopy, we found that PF-573228 decreased leukocyte rolling flux, adhesion, and emigration. We specifically examined eosinophil recruitment in vivo by using an eosinophil-GFP reporter mouse and found PF-573228 attenuated eosinophil emigration. This study reveals that a FAK inhibitor influences inflammation through its action on eosinophil recruitment.


Assuntos
Quimiotaxia de Leucócito/fisiologia , Eosinófilos/metabolismo , Proteína-Tirosina Quinases de Adesão Focal/antagonistas & inibidores , Molécula 1 de Adesão de Célula Vascular/biossíntese , Animais , Células Cultivadas , Quimiotaxia de Leucócito/efeitos dos fármacos , Inibidores Enzimáticos/farmacologia , Regulação da Expressão Gênica/efeitos dos fármacos , Humanos , Camundongos , Quinolonas/farmacologia , Sulfonas/farmacologia
11.
J Occup Med Toxicol ; 3: 24, 2008 Oct 30.
Artigo em Inglês | MEDLINE | ID: mdl-18973683

RESUMO

BACKGROUND: Swine barn air contains endotoxin and many other noxious agents. Single or multiple exposures to pig barn air induces lung inflammation and loss of lung function. However, we do not know the effect of exposure to pig barn air on inflammatory response in the lungs following a secondary infection. Therefore, we tested a hypothesis that single or multiple exposures to barn air will result in exaggerated lung inflammation in response to a secondary insult with Escherichia coli LPS (E. coli LPS). METHODS: We exposed Sprague-Dawley rats to ambient (N = 12) or swine barn air (N = 24) for one or five days and then half (N = 6/group) of these rats received intravenous E. coli LPS challenge, observed for six hours and then euthanized to collect lung tissues for histology, immunohistochemistry and ELISA to assess lung inflammation. RESULTS: Compared to controls, histological signs of lung inflammation were evident in barn exposed rat lungs. Rats exposed to barn air for one or five days and challenged with E. coli LPS showed increased recruitment of granulocytes compared to those exposed only to the barn. Control, one and five day barn exposed rats that were challenged with E. coli LPS showed higher levels of IL-1beta in the lungs compared to respective groups not challenged with E. coli LPS. The levels of TNF-alpha in the lungs did not differ among any of the groups. Control rats without E. coli LPS challenge showed higher levels of TGF-beta2 compared to controls challenged with E. coli LPS. CONCLUSION: These results show that lungs of rats exposed to pig barn air retain the ability to respond to E. coli LPS challenge.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA